Mobivity Schedules Conference Call to Discuss 2nd Quarter Fiscal 2017 Financial Results
Jul 24, 2017 12:00 pm UTC| Business
PHOENIX, July 24, 2017 -- Mobivity Holdings Corp. (OTCQB:MFON), creators of the award-winning platform for intelligent and personalized marketing in the real world, announced today the scheduling of a conference call to...
Summer Infant to Hold Conference Call for its Second Quarter 2017 Financial Results on August 3
Jul 24, 2017 12:00 pm UTC| Business
WOONSOCKET, R.I., July 24, 2017 -- Summer Infant, Inc. ("Summer Infant" or the "Company") (NASDAQ:SUMR), a global leader in premium juvenile products, today announced that it will host a conference call to discuss...
ITG Rolls Out New Triton Features Ahead of MiFID II
Jul 24, 2017 11:58 am UTC| Business
NEW YORK and LONDON, July 24, 2017 -- ITG (NYSE:ITG), a leading independent broker and financial technology provider, today announced new enhancements to its award-winning Triton execution management system (EMS) to...
Carolina Alliance Reports its Second Quarter 2017 Results
Jul 24, 2017 11:57 am UTC| Business
SPARTANBURG, S.C., July 24, 2017 -- Carolina Alliance Bank (OTCQX:CRLN) today reported its second quarter 2017 financial results. Net income available to common shareholders of $2.1 million, or $0.30 per diluted common...
Exosome Diagnostics Completes $30 Million Series C Financing
Jul 24, 2017 11:55 am UTC| Business
Waltham, Mass., July 24, 2017 -- Exosome Diagnostics Inc., a leader in the liquid biopsy market, today announced the close of its $30 million Series C financing, led by insiders, Tiger Partners and Forbion Capital...
OraQuick® HIV Self-Test Selected for Next Phase of STAR Project for HIV Self-Testing in Africa
Jul 24, 2017 11:51 am UTC| Business
BETHLEHEM, Pa., July 24, 2017 -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that its OraQuick® HIV Self-Test (HIVST) has been...
Jul 24, 2017 11:45 am UTC| Business
SOUTH PLAINFIELD, N.J., July 24, 2017 -- Admera Health, a molecular diagnostics company developing comprehensive genetic tests for the risk assessment and early diagnosis of cardiovascular diseases, cancers and...